Monitoring oesophageal pH.
M Atkinson
Gut 1987; 28: 509-514. doi:10.1136/gut.28.5.509
[PDF]
[Request Permissions]
NSAIDs--should every prescription carry a government health warning?
R Cockel
Gut 1987; 28: 515-518. doi:10.1136/gut.28.5.515
[PDF]
[Request Permissions]
Daytime gastro-oesophageal reflux is important in oesophagitis.
J S de Caestecker, J N Blackwell, A Pryde, and R C Heading
Gut 1987; 28: 519-526. doi:10.1136/gut.28.5.519
[Abstract]
[PDF]
[Request Permissions]
Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.
C P Armstrong and A L Blower
Gut 1987; 28: 527-532. doi:10.1136/gut.28.5.527
[Abstract]
[PDF]
[Request Permissions]
Prognosis of chronic duodenal ulcer: a prospective study of the effects of demographic and environmental factors and ulcer healing.
R W Nasiry, J H McIntosh, K Byth, and D W Piper
Gut 1987; 28: 533-540. doi:10.1136/gut.28.5.533
[Abstract]
[PDF]
[Request Permissions]
Gastric mucosal protection with selective inhibition of thromboxane synthesis.
R P Walt, R T Kemp, B Filipowicz, J G Davies, N K Bhaskar, and C J Hawkey
Gut 1987; 28: 541-544. doi:10.1136/gut.28.5.541
[Abstract]
[PDF]
[Request Permissions]
Transpyloric fluid movement and antroduodenal motility in patients with gastro-oesophageal reflux.
P M King, A Pryde, and R C Heading
Gut 1987; 28: 545-548. doi:10.1136/gut.28.5.545
[Abstract]
[PDF]
[Request Permissions]
Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
P Bauerfeind, T Cilluffo, C J Fimmel, C Emde, C von Ritter, W Kohler, R Gugler, T Gasser, and A L Blum
Gut 1987; 28: 549-556. doi:10.1136/gut.28.5.549
[Abstract]
[PDF]
[Request Permissions]
Comparison of maximal gastric secretion in smokers and non-smokers with and without duodenal ulcer.
P F Whitfield and M Hobsley
Gut 1987; 28: 557-560. doi:10.1136/gut.28.5.557
[Abstract]
[PDF]
[Request Permissions]
Relationship of erosive gastritis to the acid secreting area and intestinal metaplasia, and the healing effect of pirenzepine.
M Tatsuta, H Iishi, and S Okuda
Gut 1987; 28: 561-565. doi:10.1136/gut.28.5.561
[Abstract]
[PDF]
[Request Permissions]
Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.
M Deakin, H P Glenny, J K Ramage, J G Mills, W L Burland, and J G Williams
Gut 1987; 28: 566-572. doi:10.1136/gut.28.5.566
[Abstract]
[PDF]
[Request Permissions]
Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats.
R A Goodlad, T J Wilson, W Lenton, H Gregory, K G McCullagh, and N A Wright
Gut 1987; 28: 573-582. doi:10.1136/gut.28.5.573
[Abstract]
[PDF]
[Request Permissions]
Effects of exercise on mesenteric blood flow in man.
M I Qamar and A E Read
Gut 1987; 28: 583-587. doi:10.1136/gut.28.5.583
[Abstract]
[PDF]
[Request Permissions]
Spirochaetosis of the human rectum associated with an intraepithelial mast cell and IgE plasma cell response.
J O Gebbers, D J Ferguson, C Mason, P Kelly, and D P Jewell
Gut 1987; 28: 588-593. doi:10.1136/gut.28.5.588
[Abstract]
[PDF]
[Request Permissions]
Immunohistochemical Cal9-9 in primary colonic polyps and polyps synchronous with colorectal cancer.
N H Afdhal, A Long, I Tobbia, A Cullen, and D P O'Donoghue
Gut 1987; 28: 594-600. doi:10.1136/gut.28.5.594
[Abstract]
[PDF]
[Request Permissions]
Effect of changing transit time on colonic microbial metabolism in man.
A M Stephen, H S Wiggins, and J H Cummings
Gut 1987; 28: 601-609. doi:10.1136/gut.28.5.601
[Abstract]
[PDF]
[Request Permissions]
Immunoglobulin allotypes in Crohn's disease in the Netherlands.
I Biemond, G G de Lange, I T Weterman, and A S Pena
Gut 1987; 28: 610-612. doi:10.1136/gut.28.5.610
[Abstract]
[PDF]
[Request Permissions]
Salicylate induced exacerbation of ulcerative colitis.
T K Chakraborty, D Bhatia, R C Heading, and M J Ford
Gut 1987; 28: 613-615. doi:10.1136/gut.28.5.613
[Abstract]
[PDF]
[Request Permissions]
Protein losing enteropathy: an unusual presentation of intestinal schistosomiasis.
C F Kiire and N Gwavava
Gut 1987; 28: 616-618. doi:10.1136/gut.28.5.616
[Abstract]
[PDF]
[Request Permissions]
Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
M G Anderson, T J Harrison, G Alexander, A J Zuckerman, and I M Murray-Lyon
Gut 1987; 28: 619-622. doi:10.1136/gut.28.5.619
[Abstract]
[PDF]
[Request Permissions]
Problems of bacterial infection in patients with liver disease.
R J Wyke
Gut 1987; 28: 623-641. doi:10.1136/gut.28.5.623
[PDF]
[Request Permissions]